NORD Urges Congress to Ensure Access to Rare Disease Therapies; Goal is Either: Protections in Medicare Drug Bill or Passage of HR 2700

DANBURY, Conn., July 15 /U.S. Newswire/ -- The National Organization for Rare Disorders (NORD) today hailed the introduction of the Medicare Patient Access to Drugs for Rare Diseases Act of 2003 (H.R. 2700). NORD urged Congress to either pass the legislation or put similar protections into the Medicare drug legislation being considered by House and Senate conferees.

"Twenty years ago, Congress enacted the Orphan Drug Act to ensure that patients suffering from rare diseases have access to the therapies they need," said Abbey Meyers, Founder and President of NORD. "The Orphan ...

Read the rest of this article with a Free Trial at HighBeam Research.